Stockreport

Investors in Zevra Therapeutics (NASDAQ:ZVRA) have seen decent returns of 67% over the past year [Yahoo! Finance]

Zevra Therapeutics, Inc.  (ZVRA) 
PDF Zevra Therapeutics, Inc. NASDAQ:ZVRA ) share price is up 67% in the last 1 year, clearly besting the market return of around 33% (not including dividends). If it can ke [Read more]